Stock listing
ABOS Stock Price, News, Filings & Events — Acumen Pharmaceuticals, Inc.
Selected listing: ABOS · NASDAQ · USD · US
This page tracks Acumen Pharmaceuticals, Inc.'s ABOS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABOS:NASDAQ. ABOS:NASDAQ is the stock-level entry point for investors researching Acumen Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Acumen Pharmaceuticals, Inc. (ticker: ABOS) is a public company based in the United States, with a market capitalization of approximately $162.5 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Acumen aims to address significant unmet medical needs in the field of Alzheimer's disease and related conditions.
- Ticker
- ABOS:NASDAQ
- Asset type
- Stock
- Market cap
- $228.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Acumen Pharmaceuticals, Inc. ABOS:NASDAQ stock context
This page tracks Acumen Pharmaceuticals, Inc.'s ABOS:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ABOS:NASDAQ. ABOS:NASDAQ is the stock-level entry point for investors researching Acumen Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Acumen Pharmaceuticals, Inc. (ticker: ABOS) is a public company based in the United States, with a market capitalization of approximately $162.5 million. The company focuses on developing innovative therapies for neurodegenerative diseases. Acumen aims to address significant unmet medical needs in the field of Alzheimer's disease and related conditions.
Latest news from Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzhei...
July 7, 2026
Acumen Pharmaceuticals Announces Nomination of Two Enhanced Brain Delivery™ (EBD™) Development Candidates for the Treatment of Alzheimer’...
June 16, 2026
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
May 12, 2026
Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference
May 7, 2026
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026
May 5, 2026
Acumen Pharmaceuticals, Inc. earnings calls
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2026 Earnings Call
August 12, 2026 · Replay with transcript and chapters
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call
March 26, 2026 · Replay with transcript and chapters
Acumen Pharmaceuticals, Inc. (ABOS) Q3 2025 Earnings Call
November 12, 2025 · Replay with transcript and chapters
Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for ABOS:NASDAQ.
Acumen Pharmaceuticals, Inc. company profile
View the public company page for Acumen Pharmaceuticals, Inc. on 6ix.
Acumen Pharmaceuticals, Inc. news
Read company news and market updates connected to Acumen Pharmaceuticals, Inc..
Acumen Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Acumen Pharmaceuticals, Inc..